1887

Abstract

The rapid diagnosis of septicaemic melioidosis will have an impact on reduction of mortality. Currently, this relies almost exclusively upon culture of the causative agent from clinical samples. In acute sepsis, blood is the preferred specimen for culture and therefore should be the target for a rapid diagnostic tool. A lateral flow immunoassay (LFI) for the detection of antigen has been developed. This was compared with molecular detection using the targets and . Forty-five clinical samples of EDTA blood, which were culture-positive, were tested using both modalities. The LFI had a sensitivity of 40 %, whilst molecular detection had a sensitivity of 20 %. The poor performance of molecular detection has been described previously and is largely related to the use of whole-blood specimens collected into blood tubes containing EDTA. Whilst suboptimal, the LFI would be an adjunct in the rapid diagnosis of melioidosis.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000098
2015-08-01
2019-10-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/64/8/845.html?itemId=/content/journal/jmm/10.1099/jmm.0.000098&mimeType=html&fmt=ahah

References

  1. Couto M.S., Cordeiro R.A., Rocha M.F., Grangeiro T.B., Leitão Junior N.P., Bandeira T.J., Sidrim J.J., Brilhante R.S.. ( 2009;). A diagnosis of Burkholderia pseudomallei directly in a bronchoalveolar lavage by polymerase chain reaction. Diagn Microbiol Infect Dis 65: 73–75 [CrossRef] [PubMed].
    [Google Scholar]
  2. Ekpo P., Rungpanich U., Pongsunk S., Naigowit P., Petkanchanapong V.. ( 2007;). Use of protein-specific monoclonal antibody-based latex agglutination for rapid diagnosis of Burkholderia pseudomallei infection in patients with community-acquired septicemia. Clin Vaccine Immunol 14: 811–812 [CrossRef] [PubMed].
    [Google Scholar]
  3. Gilmore G., Barnes J., Ketheesan N., Norton R.. ( 2007;). Use of antigens derived from Burkholderia pseudomallei, B thailandensis B. cepacia in the indirect hemagglutination assay for melioidosis. Clin Vaccine Immunol 14: 1529–1531 [CrossRef] [PubMed].
    [Google Scholar]
  4. Harris P., Owens L., Ketheesan N., Norton R.. ( 2009;). Clinical features that affect indirect-hemagglutination-assay responses to Burkholderia pseudomallei. Clin Vaccine Immunol 16: 924–930 [CrossRef] [PubMed].
    [Google Scholar]
  5. Houghton R.L., Reed D.E., Hubbard M.A., Dillon M.J., Chen H., Currie B.J., Mayo M., Sarovich D.S., Theobald V., other authors. ( 2014;). Development of a prototype lateral flow immunoassay (LFI) for the rapid diagnosis of melioidosis. PLoS Negl Trop Dis 8: e2727 [CrossRef] [PubMed].
    [Google Scholar]
  6. Kaestli M., Richardson L.J., Colman R.E., Tuanyok A., Price E.P., Bowers J.R., Mayo M., Kelley E., Seymour M.L., other authors. ( 2012;). Comparison of TaqMan PCR assays for detection of the melioidosis agent Burkholderia pseudomallei in clinical specimens. J Clin Microbiol 50: 2059–2062 [CrossRef] [PubMed].
    [Google Scholar]
  7. Kunakorn M., Raksakait K., Sethaudom C., Sermswan R.W., Dharakul T.. ( 2000;). Comparison of three PCR primer sets for diagnosis of septicemic melioidosis. Acta Trop 74: 247–251 [CrossRef] [PubMed].
    [Google Scholar]
  8. Malczewski A.B., Oman K.M., Norton R.E., Ketheesan N.. ( 2005;). Clinical presentation of melioidosis in Queensland, Australia. Trans R Soc Trop Med Hyg 99: 856–860 [CrossRef] [PubMed].
    [Google Scholar]
  9. Merritt A., Inglis T.J., Chidlow G., Harnett G.. ( 2006;). PCR-based identification of Burkholderia pseudomallei. Rev Inst Med Trop Sao Paulo 48: 239–244 [CrossRef] [PubMed].
    [Google Scholar]
  10. Meumann E.M., Novak R.T., Gal D., Kaestli M.E., Mayo M., Hanson J.P., Spencer E., Glass M.B., Gee J.E., other authors. ( 2006;). Clinical evaluation of a type III secretion system real-time PCR assay for diagnosing melioidosis. J Clin Microbiol 44: 3028–3030 [CrossRef] [PubMed].
    [Google Scholar]
  11. Pankla R., Buddhisa S., Berry M., Blankenship D.M., Bancroft G.J., Banchereau J., Lertmemongkolchai G., Chaussabel D.. ( 2009;). Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol 10: R127 [CrossRef] [PubMed].
    [Google Scholar]
  12. Pongsunk S., Thirawattanasuk N., Piyasangthong N., Ekpo P.. ( 1999;). Rapid identification of Burkholderia pseudomallei in blood cultures by a monoclonal antibody assay. J Clin Microbiol 37: 3662–3667 [PubMed].
    [Google Scholar]
  13. Richardson L.J., Kaestli M., Mayo M., Bowers J.R., Tuanyok A., Schupp J., Engelthaler D., Wagner D.M., Keim P.S., Currie B.J.. ( 2012;). Towards a rapid molecular diagnostic for melioidosis: comparison of DNA extraction methods from clinical specimens. J Microbiol Methods 88: 179–181 [CrossRef] [PubMed].
    [Google Scholar]
  14. Supaprom C., Wang D., Leelayuwat C., Thaewpia W., Susaengrat W., Koh V., Ooi E.E., Lertmemongkolchai G., Liu Y.. ( 2007;). Development of real-time PCR assays and evaluation of their potential use for rapid detection of Burkholderia pseudomallei in clinical blood specimens. J Clin Microbiol 45: 2894–2901 [CrossRef] [PubMed].
    [Google Scholar]
  15. Tomaso H., Pitt T.L., Landt O., Al Dahouk S., Scholz H.C., Reisinger E.C., Sprague L.D., Rathmann I., Neubauer H.. ( 2005;). Rapid presumptive identification of Burkholderia pseudomallei with real-time PCR assays using fluorescent hybridization probes. Mol Cell Probes 19: 9–20 [CrossRef] [PubMed].
    [Google Scholar]
  16. White N.J.. ( 2003;). Melioidosis. Lancet 361: 1715–1722 [CrossRef] [PubMed].
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000098
Loading
/content/journal/jmm/10.1099/jmm.0.000098
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error